Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.

Sansure Celebrates Acquisition of MDSAP Certification

From December 19th to 22nd, 2023, Sansure underwent a three-and-a-half-day MDSAP quantity management system certification audit. Through the close collaboration and joint efforts of various departments within the company, Sansure successfully passed this stringent audit and obtained the certification.   The MDSAP certification is not only a significant achievement for Sansure but also a key milestone in its internationalization strategy. […]

Sansure’s New Immunoassay Product Kicks off a New Era of Eelectrochemiluminescence Immunoassay

Recently, Sansure Biotech officially launched a new immunoassay product – Accucise Enhanced Electrochemiluminescence Platform at its 15th Anniversary Celebration. Under the joint witness of more than 2,000 attendees, a new era of electrochemiluminescence (ECL) immunoassay was opened. Dr. Yin Peng, the Senior Vice President and Chief Technology Officer of Sansure Biotech and the Chairman and General Manager of Accucise Diagnostics, […]

Sansure Shanghai Industrial Park Unveils – a New Starting Point for Globalization

Minhang District, Shanghai, January 11, 2024 – Prominent officials and industry experts gathered today for the grand opening of Sansure Shanghai Industrial Park. Mr. Huang Zanjia, Secretary of the Party Leadership Group and Director of the Shanghai Office, the People’s Government of Hunan Province, and Mr. Li Rui, Vice Mayor of Minhang District, graced the ceremony alongside other dignitaries and […]

Sansure Obtains CE Mark Under IVDR Certification for Surelite Automated CLIA System

Sansure Biotech has achieved a milestone in the field of immunodiagnostics, marking significant progress in international strategic expansion. On the evening of November 14, Sansure Biotech announced that its automated chemiluminescence immunoassay (CLIA) systems recently received the EU CE IVDR certification. The announcement indicates that Surelite 8 and Surelite 16 automated CLIA systems were certified. These systems, along with the […]

Six New Products of Sansure-Controlled Company were Approved Marking a Breakthrough in Chemiluminescence Layout

Sansure Biotech Inc. has made a breakthrough in the field of chemiluminescence immunoassay. Recently, six products independently developed by Accucise Diagnostics Inc., a company controlled by Sansure, obtained medical device registration certificates. These medical device registration certificates were issued by Jiangsu Medical Products Administration (JSMPA). The approved products include the reagents and quality controls of Procalcitonin Detection Kit (Electrochemiluminescence Method) […]

1 2 3 10
Get in touch with us
I confirm that I have reviewed Sansure's Privacy Policy and agree with the collection and storage of my personal data.

Thank you!

We shall contact you soon!
Back Top